In addition to that, although the proliferative cells also stained for multiple antibodies that provided proof of different sarcoma-like differentiation processes occurring, such as CD31, CD34, SMA, etc., these stains were focal at most, with no geographical overlap being reserved to the locations where the proliferation showed the appropriate dedifferentiation for the proper stain. The gene discussed is SMN1; the disease is sarcoma.